SCHEDULE: Soleus Capital Files Joint Agreement for Evolus Stake

Soleus Capital entities and Guy Levy have filed a joint filing agreement for Schedule 13G concerning their beneficial ownership of Evolus, Inc. common stock.

Summary

• This filing is a Joint Filing Agreement for Schedule 13G, indicating that Soleus Capital Master Fund, L.P., along with related entities and Guy Levy, will file jointly regarding their beneficial ownership of Evolus, Inc. common stock.
• The agreement outlines that each party is responsible for the timely filing and accuracy of information concerning themselves, but not for other parties unless they have reason to believe information is inaccurate.
• The filing confirms that Soleus Capital Master Fund, L.P. holds 3,480,000 shares of Evolus, Inc. common stock, representing 5.3% of the class.
• This percentage is calculated based on 66,050,440 shares outstanding as of July 31, 2026, as reported in Evolus, Inc.'s Form 10-Q filed on August 5, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily concerns a joint filing agreement for Schedule 13G, indicating a change in reporting structure rather than a fundamental shift in the company's operations or financial health.

Positives

• Clear disclosure of beneficial ownership for a significant stake (5.3%) in Evolus, Inc. by Soleus Capital entities.
• The joint filing agreement establishes a clear framework for reporting obligations among the involved parties.

Negatives

• The filing does not contain any financial performance data or operational updates for Evolus, Inc., limiting insights into the company's health.
• The disclaimer of beneficial ownership by entities other than the Master Fund for purposes beyond Section 13(d) obligations may obscure ultimate control or influence.

Risks

• Potential for future changes in beneficial ownership or investment strategy by Soleus Capital, which could impact Evolus, Inc.'s stock price.
• The disclaimer of beneficial ownership by related entities could lead to ambiguity regarding the true extent of influence over Evolus, Inc.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Evolus, Inc.'s future performance. It solely pertains to the reporting of beneficial ownership.

Management Comments

• Each party is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors acquiring a significant stake (typically 5% or more) in a public company. This filing indicates Soleus Capital's substantial interest in Evolus, Inc., but without further context on their investment strategy, its implications remain to be seen.

Stakeholder Impact

• Shareholders of Evolus, Inc. are informed of a significant beneficial owner, Soleus Capital, and the coordinated reporting structure.
• Potential investors may use this information to assess the ownership landscape and potential influence on the company.

Next Steps

• Soleus Capital entities and Guy Levy will continue to file joint statements on Schedule 13G and any necessary amendments.
• Monitoring future filings by Soleus Capital for any changes in their beneficial ownership or investment strategy concerning Evolus, Inc.

Key Dates

Keywords

Schedule 13G, Joint Filing Agreement, Beneficial Ownership, Evolus, Inc., Soleus Capital, Securities Exchange Act